Molecular targeting of liposomal nano-particles to lymphatic system

Current Cancer Drug Targets

Volumn 11, Issue 2, 2011, Pages 147-155

  Cuong, Nguyen Van ^a,b   Hsieh, Ming Fa ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^b INDUSTRIAL UNIVERSITY OF HO CHI MINH CITY   (Viet Nam)

Author keywords

Immunoliposome; Lymphatic system; Metastasis; Stealth liposome; Targeted drug delivery system

Indexed keywords

ANTIBODY CONJUGATE; AVIDIN; BIOTIN; CAMPTOTHECIN; CHOLESTEROL; DICETYL PHOSPHATE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DOXORUBICIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HONOKIOL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLIPOSOME; LIPOSOME; MACROGOL; MACROGOL 2000; NANOPARTICLE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; POLYMER; RICIN; RICIN TOXOID VACCINE; TOXOID; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CHEMICAL STRUCTURE; CIRCULATION; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; LIVER; LYMPHATIC SYSTEM; METASTASIS; NEOPLASM; NONHUMAN; RETICULOENDOTHELIAL SYSTEM; REVIEW; SPLEEN;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; LYMPHOPROLIFERATIVE DISORDERS; NANOPARTICLES; TISSUE DISTRIBUTION;

EID: 79551626514     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800911794328439     Document Type: Review

References (66)

1. Achen, M. G.; Mann, G. B.; Stacker, S. A. Targeting lymphangiogenesis to prevent tumour metastasis. Br. J. Cancer 2006, 94, 1355-1360.
2. Mehlen, P.; Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 2006, 6(6), 449-458.
3. Swartz, M. A. The physiology of the lymphatic system. Adv. Drug Deliv. Rev. 2001, 50(1-2), 3-20.
4. Geiger, T. R.; Peeper, D. S. Metastasis mechanisms. Biochim. Biophys. Acta-Rev. Cancer 2009, 1796(2), 293-308.
5. Padera, T. P.; Kadambi, A.; di Tomaso, E.; Carreira, C. M.; Brown, E. B.; Boucher, Y.; Choi, N. C.; Mathisen, D.; Wain, J.; Mark, E. J.; Munn, L. L.; Jain, R. K. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296(5574), 1883-1886.
6. Wyckoff, J.; Wang, W.; Lin, E. Y.; Wang, Y.; Pixley, F.; Stanley, E. R.; Graf, T.; Pollard, J. W.; Segall, J.; Condeelis, J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004, 64(19), 7022-7029.
7. Caliph, S. M.; Charman, W. N.; Porter, C. J. H. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and noncannulated rats. J. Pharm. Sci. 2000, 89(8), 1073-1084.
8. Lind, M. L.; Jacobsen, J.; Holm, R.; Müllertz, A. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: The influence of polysorbate 60 and 80. Eur. J. Pharm. Sci. 2008, 35(3), 211-218.
9. Yoshikawa, H. Lymphatic delivery in 'rectal drug delivery systems'. Adv. Drug Deliv. Rev. 1997, 28(2), 239-251.
10. Moghimi, S. M.; Moghimi, M. Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation. Biochim. Biophys. Acta-Biomembr. 2008, 1778(1), 51-55.
11. Faraji, A. H.; Wipf, P. Nanoparticles in cellular drug delivery. Bioorg. Med. Chem. 2009, 17(8), 2950-2962.
12. Peer, D.; Karp, J. M.; Hong, S.; FaroKhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2(12), 751-760.
13. Kukowska-Latallo, J. F.; Candido, K. A.; Cao, Z.; Nigavekar, S. S.; Majoros, I. J.; Thomas, T. P.; Balogh, L. P.; Khan, M. K.; Baker, J. R., Jr. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65(12), 5317-5324.
14. Blanco, E.; Kessinger, C. W.; Sumer, B. D.; Gao, J. Multifunctional micellar nanomedicine for cancer therapy. Exp. Biol. Med. 2009, 234(2), 123-131.
15. Cuong, N. V.; Hsieh, M. F.; Huang, C. M. Recent development in nano-sized dosage forms of plant alkaloid camptothecin-derived drugs. Recent Patents Anti-Canc. Drug Discov. 2009, 4, 254-261.
16. Debbage, P. Targeted drugs and nanomedicine: present and future. Curr. Pharm. Des. 2009, 15, 153-172.
17. Nishioka, Y.; Yoshino, H. Lymphatic targeting with nanoparticulate system. Adv. Drug Deliv. Rev. 2001, 47(1), 55-64.
18. Videira, M. A.; Gano, L.; Santos, C.; Neves, M.; Almeida, A. J. Lymphatic uptake of lipid nanoparticles following endotracheal administration. J. Microencapsul. 2006, 23, 855-862.
19. Shin, S. B.; Cho, H. Y.; Kim, D. D.; Choi, H. G.; Lee, Y. B. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery. Eur. J. Pharm. Biopharm. 2010, 74(2), 164-171.
20. Torabi, M.; Aquino, S. L.; Harisinghani, M. G. Current concepts in lymph node imaging. J. Nucl. Med. 2004, 45(9), 1509-1518.
21. Gagné, J.-F.; Désormeaux, A.; Perron, S.; Tremblay, M. J.; Bergeron, M. G. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochim. Biophys. Acta- Biomembr. 2002, 1558(2), 198-210.
22. Vyas, T. K.; Shah, L.; Amiji, M. M. Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites. Expert Opin. Drug Deliv. 2006, 3(5), 613-628.
23. Pérez-López, M. E.; Curiel, T.; Gómez, J. G.; Jorge, M. Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer. Anti-Cancer Drugs. 2007, 18(5), 611-617.
24. Griffiths, G. D.; Bailey, S. C.; Hambrook, J. L.; Keyte, M.; Jayasekera, P.; Miles, J.; Williamson, E. Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin. Vaccine 1997, 15(17-18), 1933-1939.
25. Porter, C. J. H.; Charman, W. N. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 2001, 50(1-2), 61-80.
26. Yang, F.; Fu, D. L.; Long, J.; Ni, Q. X. Magnetic lymphatic targeting drug delivery system using carbon nanotubes. Medical Hypotheses 2008, 70(4), 765-767.
27. Oussoren, C.; Storm, G. Liposomes to target the lymphatics by subcutaneous administration. Adv. Drug Deliv. Rev. 2001, 50(1-2), 143-156.
28. Oussoren, C.; Zuidema, J.; Crommelin, D. J. A.; Storm, G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection I. Influence of the anatomical site of injection. J. Liposome Res. 1997, 7(1), 85-99.
29. Oussoren, C.; Storm, G. Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration. Int. J. Pharm. 1999, 183(1), 37-41.
30. Oussoren, C.; Zuidema, J.; Crommelin, D. J. A.; Storm, G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.: II. Influence of liposomal size, lipid composition and lipid dose. Biochim. Biophys. Acta-Biomembr. 1997, 1328(2), 261-272.
31. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53(2), 283-318.
32. Moghimi, S. M.; Szebeni, J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42(6), 463-478.
33. Oussoren, C.; Storm, G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol). Pharm. Res. 1997, 14(10), 1479-1484.
34. Moghimi, S. M. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes. Biomaterials 2006, 27(1), 136-144.
35. Moghimi, S. M.; Hawley, A. E.; Christy, N. M.; Gray, T.; Illum, L.; Davis, S. S. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett. 1994, 344(1), 25-30.
36. Medina, O. P.; Zhu, Y.; Kairemo, K. Targeted liposomal drug delivery in cancer. Curr. Pharm. Des. 2004, 10, 2981-2989.
37. Park, J. W.; Benz, C. C.; Martin, F. J. Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin. Oncol. 2004, 31(Supplement 13), 196-205.
38. Hansen, C. B.; Kao, G. Y.; Moase, E. H.; Zalipsky, S.; Allen, T. M. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta-Biomembr. 1995, 1239(2), 133-144.
39. Tirosh, O.; Barenholz, Y.; Katzhendler, J.; Priev, A. Hydration of polyethylene glycol-grafted liposomes. Biophys. J. 1998, 74(3), 1371-1379.
40. Moghimi, M.; Moghimi, S. M. Lymphatic targeting of immuno- PEG-liposomes: Evaluation of antibody-coupling procedures on lymph node macrophage uptake. J. Drug Target 2008. 16, 586-590.
41. Phillips, W. T.; Klipper, R.; Goins, B. Novel method of greatly enhanced delivery of liposomes to lymph nodes. J. Pharmacol. Exp. Ther. 2000, 295(1), 309-313.
42. Phillips, W. T.; Medina, L. A.; Klipper, R.; Goins, B. A novel approach for the increased delivery of pharmaceutical agents to peritoneum and associated lymph nodes. J. Pharmacol. Exp. Ther. 2002, 303(1), 11-16.
43. Medina, L. A.; Calixto, S. M.; Klipper, R.; Phillips, W. T.; Goins, B. Avidin/biotin-liposome system injected in the pleural space for drug delivery to mediastinal lymph nodes. J. Pharm. Sci. 2004, 93(10), 2595-2608.
44. Medina, L. A.; Calixto, S. M.; Klipper, R.; Li, Y.; Phillips, W. T.; Goins, B. Mediastinal node and diaphragmatic targeting after intracavitary injection of avidin/99mTc-blue-biotin-liposome system. J. Pharm. Sci. 2006, 95(1), 207-224.
45. Zavaleta, C. L.; Phillips, W. T.; Soundararajan, A.; Goins, B. A. Use of avidin/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model. Int. J. Pharm. 2007, 337(1-2), 316-328.
46. Minisini, A. M.; Andreetta, C.; Fasola, G.; Puglisi, F. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer. Expert Rev. Anticancer Ther. 2008, 8(3), 331-342.
47. Cuong, N. V.; Hsieh, M. F. Recent advances in pharmacokinetics of polymeric excipients used in nanosized anti-cancer drugs. Curr. Drug Metab. 2009, 10, 842-850.
48. Oussoren, C.; Storm, G. Targeting to lymph nodes by subcutaneous administration of liposomes. Int. J. Pharm. 1998, 162(1-2), 39-44.
49. Oussoren, C.; Velinova, M.; Scherphof, G.; van der Want, J. J.; van Rooijen, N.; Storm, G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes. Biochim. Biophys. Acta-Biomembr. 1998, 1370(2), 259-272.
50. Hideo, K.; Yasuhiko, I.; Osamu, M.; Yoshihiko, K.; Keiji, I.; Osamu, N. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog. J. Urol. 1999, 161(2), 665-667.
51. Chen, J.; Wang, L.; Yao, Q.; Ling, R.; Li, K.; Wang, H. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer. Breast Cancer Res. 2004, 6(4), R474-R477.
52. Rui, L.; Yu, L.; Qing, Y.; Tao, C.; Desheng, Z.; Yi, J.; Jianghao, C. Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model. J. Drug Target 2005, 13, 137-142.
53. Konno, H.; Tadakuma, T.; Kumai, K.; Takahashi, T.; Ishibiki, K.; Abe, O.; Sakaguchi, S. The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases. Surg. Today 1990, 20(4), 424-428.
54. Chen, J. H.; Ling, R.; Yao, Q.; Li, Y.; Chen, T.; Wang, Z.; Li, K. Z. Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model. Endocr. Relat. Cancer 2005, 12(1), 93-100.
55. Xie, Y.; Bagby, T. R.; Cohen, M.; Forrest, M. L. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert. Opin. Drug Deliv. 2009, 6(8), 785-792.
56. Xiaojun, L.; Hong, Q.; Jia, Y.; Jiansheng, W.; Yinsheng, X.; Yunfeng, Z.; Hong, R. Local administration of liposomal adriamycin inhibited proliferation of metastatic cells in axillary lymph nodes in rabbit breast cancer model. J. Med. Coll. PLA. 2009, 24(3), 161-166.
57. Stacker, S. A.; Achen, M. G.; Jussila, L.; Baldwin, M. E.; Alitalo, K. Metastasis: Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2002, 2(8), 573-583.
58. Mandriota, S. J.; Jussila, L.; Jeltsch, M.; Compagni, A.; Baetens, D.; Prevo, R.; Banerji, S.; Huarte, J.; Montesano, R.; Jackson, D. G.; Orci, L.; Alitalo, K.; Christofori, G.; Pepper, M. S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001, 20(4), 672-682.
59. Hou, W.; Chen, L.; Yang, G.; Zhou, H.; Jiang, Q.; Zhong, Z.; Hu, J.; Chen, X.; Wang, X.; Yuan, Y.; Tang, M.; Wen, J.; Wei, Y. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother. Res. 2008, 22(8), 1125-1132.
60. Wen, J.; Fu, A. F.; Chen, L. J.; Xie, X. J.; Yang, G. L.; Chen, X. C.; Wang, Y. S.; Li, J.; Chen, P.; Tang, M. H.; Shao, X. M.; Lu, Y.; Zhao, X.; Wei, Y. Q. Liposomal honokiol inhibits VEGF-Dinduced lymphangiogenesis and metastasis in xenograft tumor model. Int. J. Cancer 2009, 124(11), 2709-2718.
61. Pramanik, M.; Song, K. H.; Swierczewska, M.; Green, D.; Sitharaman, B.; Wang, L. V. In vivo carbon nanotube-enhanced non-invasive photoacoustic mapping of the sentinel lymph node. Phys. Med. Biol. 2009, 54, 3291.
62. Yang, D.; Yang, F.; Hu, J.; Long, J.; Wang, C.; Fu, D.; Ni, Q. Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehicles. Chem. Commun. 2009, 29, 4447-4449.
63. Liu, N. F.; Lu, Q.; Jiang, Z. H.; Wang, C. G.; Zhou, J. G. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography. J. Vasc. Surg. 2009, 49(4), 980-987.
64. Kaminskas, L. M.; Kota, J.; McLeod, V. M.; Kelly, B. D.; Karellas, P.; Porter, C. J. H. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. J. Control. Release 2009, 140(2), 108-116.
65. Bhang, S. H.; Won, N.; Lee, T. J.; Jin, H.; Nam, J.; Park, J.; Chung, H.; Park, H. S.; Sung, Y. E.; Hahn, S. K.; Kim, B. S.; Kim, S. Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging. ACS Nano. 2009, 3(6), 1389-1398.
66. Luo, G.; Yu, X.; Jin, C.; Yang, F.; Fu, D.; Long, J.; Xu, J.; Zhan, C.; Lu, W. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int. J. Pharm. 2010, 385(1-2), 150-156.